Commonwealth Equity Services, LLC Galectin Therapeutics Inc Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 483,264 shares of GALT stock, worth $502,594. This represents 0.0% of its overall portfolio holdings.

Number of Shares

483,264

Previous 483,351 0.02%

Holding current value

$502,594

Previous $1.09 Million 21.7%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$2.04 - $2.86 $177 - $248	-87 Reduced 0.02%	483,264 $1.33 Million
Q2 2024 Jul 31, 2024	BUY	$2.13 - $4.2 $783,009 - $1.54 Million	367,610 Added 317.61%	483,351 $1.09 Million
Q1 2024 Apr 29, 2024	BUY	$1.6 - $2.44 $16,568 - $25,266	10,355 Added 9.83%	115,741 $277,000
Q4 2023 Feb 06, 2024	SELL	$1.6 - $2.18 $1,817 - $2,476	-1,136 Reduced 1.07%	105,386 $175,000
Q3 2023 Oct 23, 2023	BUY	$1.38 - $1.97 $6,899 - $9,850	5,000 Added 4.93%	106,522 $205,000
Q4 2022 Feb 07, 2023	BUY	$1.03 - $1.66 $65,201 - $105,081	63,302 Added 165.63%	101,522 $114,000
Q2 2022 Jul 19, 2022	BUY	$1.19 - $1.74 $13,468 - $19,693	11,318 Added 42.07%	38,220 $50,000
Q1 2022 May 04, 2022	BUY	$1.61 - $2.31 $16,100 - $23,100	10,000 Added 59.16%	26,902 $43,000
Q4 2021 Jan 31, 2022	BUY	$2.07 - $3.8 $10,350 - $19,000	5,000 Added 42.01%	16,902 $34,000
Q3 2021 Oct 29, 2021	BUY	$2.59 - $4.15 $30,826 - $49,393	11,902 New	11,902 $46,000
Q4 2019 Feb 05, 2020	SELL	$2.79 - $4.32 $45,622 - $70,640	-16,352 Closed	0 $0
Q3 2019 Oct 30, 2019	BUY	$3.0 - $4.05 $3,315 - $4,475	1,105 Added 7.25%	16,352 $60,000
Q2 2019 Jul 19, 2019	BUY	$3.61 - $5.0 $11,042 - $15,295	3,059 Added 25.1%	15,247 $63,000
Q1 2019 May 13, 2019	BUY	$3.86 - $6.02 $3,860 - $6,020	1,000 Added 8.94%	12,188 $62,000
Q4 2018 Feb 11, 2019	BUY	$3.43 - $5.74 $38,374 - $64,219	11,188 New	11,188 $38,000

Others Institutions Holding GALT

# of Institutions

Shares Held

9.65M

Call Options Held

1.16M

Put Options Held

1.98M

View Full List

About GALECTIN THERAPEUTICS INC

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $61.8M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

More about GALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Galectin Therapeutics Inc Transaction History